Journal of Biological Chemistry

The 2023 Aspirnaut summer research interns, flanked by the program’s co-founders, Julie Hudson, MD, left, and Billy Hudson, PhD, back row, right. (photo by Susan Urmy)

Student researchers at VUMC earn accolades for their report

A research paper co-authored by 23 high school and undergraduate students participating in Vanderbilt University Medical Center’s Aspirnaut summer research program has been selected as one of the “Editor’s Picks” by the Journal of Biological Chemistry.

A speedier treatment for depression?

Vanderbilt researchers used a computer-based search to identify a compound with promise as a new, mechanistically distinct and rapid-acting therapy for major depressive disorder.

Regulators of fat cell metabolism

Vanderbilt researchers have discovered new details of the regulation of fat cell metabolism, findings that are important for combating obesity.

Potential protection from atherosclerosis

Vanderbilt researchers have discovered a potential way to reduce atherosclerosis: blocking the modification of an HDL-associated enzyme by reactive molecules called isolevuglandins.

New insights into kidney development

Integrin-linked kinase, a central component of a complex that coordinates cell signaling involved in migration, proliferation and cell death, plays a role in kidney development and epithelial cell function.

Arrhythmia culprit: supertrafficking ion channel

Charles Sanders, PhD, and colleagues show how a “supertrafficking” mutant potassium channel contributes to heart rhythm abnormalities.

1 2 3 4